GENEVA, SWITZERLAND / ACCESSWIRE / September 15, 2023 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical…
Brand and visual identity demonstrate the best of Johnson & Johnson’s care and humanity, while capturing the Company’s passion and…
BANGALORE, India, Sept. 14, 2023 /PRNewswire/ -- Digital Biomarker Market is Segmented by Type (Passive Digital Biomarker, Active Digital Biomarker),…
NEW YORK, Sept. 14, 2023 /PRNewswire/ -- Cinctive Capital Management ("Cinctive") today announced the addition of four investment professionals further…
LONDON, Sept. 14, 2023 /PRNewswire/ -- According to a comprehensive research report by Brandessence Market Research (BMRC), "Healthcare Cognitive Computing…
NEW YORK, Sept. 14, 2023 /PRNewswire/ -- ProofPilot, a leading provider of innovative clinical trial automation, and Legacy Health Strategies,…
BURLINGTON, N.C., Sept. 14, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, is hosting…
The positive opinion follows the recommendation from regulators and global public health bodies to develop monovalent XBB.1.5 COVID-19 vaccines for…
Combining the world-class clinical and research expertise of Mayo Clinic with the deep research, engineering, and product development expertise of…
Click here to access webcast replayTop line results expected late October 2023 for company's phase 3 OnTarget trial of crofelemer…